Neutralizing epitopes on herpes simplex virus-1-expressed rotavirus VP7 are dependent on coexpression of other rotavirus proteins
Authors:
- Philip RdormitzerPRPhilip Rdormitzer
- Dora Y. HoDHDora Y. Ho
- Erich R. MackowjEMErich R. Mackowj
- Edward S. MocarskiEMEdward S. Mocarski
- Harry B. GreenbergHGHarry B. Greenberg
Open Access
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- A Field Study of the Safety and Efficacy of Two Candidate Rotavirus Vaccines in a Native American PopulationThe Journal of Infectious Diseases, 1991
- In Vivo Behavior of Genetically Engineered Herpes Simplex Viruses R7017 and R7020: Construction and Evaluation in RodentsThe Journal of Infectious Diseases, 1988
- TRIAL OF AN ATTENUATED BOVINE ROTAVIRUS VACCINE (RIT 4237) IN GAMBIAN INFANTSThe Lancet, 1987
- PROTECTIVE EFFECT OF NATURALLY ACQUIRED HOMOTYPIC AND HETEROTYPIC ROTAVIRUS ANTIBODIESThe Lancet, 1986
- FAILURE OF LIVE, ATTENUATED ORAL ROTAVIRUS VACCINEThe Lancet, 1986
- Deletions into an NH2-terminal hydrophobic domain result in secretion of rotavirus VP7, a resident endoplasmic reticulum membrane glycoprotein.Journal of Cell Biology, 1985
- Clinical Immunity after Neonatal Rotavirus InfectionNew England Journal of Medicine, 1983
- Molecular engineering of the herpes simplex virus genome: Insertion of a second L-S junction into the genome causes additional genome inversionsCell, 1980
- Activation of rotavirus RNA polymerase by calcium chelationArchives of Virology, 1979
- Tunicamycin inhibition of polyisoprenyl N-acetylglucosaminyl pyrophosphate formation in calf-liver microsomesBiochemical and Biophysical Research Communications, 1975